Nisa Investment Advisors, LLC Enanta Pharmaceuticals Inc Transaction History

Nisa Investment Advisors, LLC

$24.1 Billion
Q4 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 535 shares of ENTA stock, worth $2,733. This represents 0.0% of its overall portfolio holdings.

Number of Shares

535

Previous 2,827 81.08%

Holding current value

$2,733

Previous $29,000 89.66%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 17, 2025	SELL	$5.75 - $12.99 $13,179 - $29,773	-2,292 Reduced 81.08%	535 $3,000
Q3 2024 Oct 24, 2024	SELL	$10.05 - $16.54 $592 - $975	-59 Reduced 2.04%	2,827 $29,000
Q2 2024 Jul 19, 2024	BUY	$11.43 - $17.02 $674 - $1,004	59 Added 2.09%	2,886 $37,000
Q4 2023 Jan 25, 2024	BUY	$8.18 - $10.78 $18,658 - $24,589	2,281 Added 417.77%	2,827 $26,000
Q3 2023 Nov 02, 2023	BUY	$11.09 - $22.13 $399 - $796	36 Added 7.06%	546 $6,000
Q2 2023 Aug 11, 2023	BUY	$20.68 - $39.85 $6,886 - $13,270	333 Added 188.14%	510 $10,000
Q1 2023 May 02, 2023	SELL	$38.82 - $54.59 $29,115 - $40,942	-750 Reduced 80.91%	177 $7,000
Q4 2022 Feb 02, 2023	SELL	$40.77 - $53.73 $366 - $483	-9 Reduced 0.96%	927 $43,000
Q3 2022 Nov 07, 2022	SELL	$48.29 - $71.27 $13,086 - $19,314	-271 Reduced 22.45%	936 $42,000
Q2 2022 Aug 03, 2022	BUY	$38.13 - $76.93 $28,597 - $57,697	750 Added 164.11%	1,207 $57,000
Q1 2022 Apr 29, 2022	SELL	$56.06 - $74.11 $60,376 - $79,816	-1,077 Reduced 70.21%	457 $33,000
Q4 2021 Feb 03, 2022	SELL	$60.19 - $97.37 $173,708 - $281,009	-2,886 Reduced 65.29%	1,534 $91,000
Q3 2021 Oct 18, 2021	SELL	$41.02 - $58.65 $82,614 - $118,121	-2,014 Reduced 31.3%	4,420 $251,000
Q4 2020 Jan 25, 2021	BUY	$41.16 - $47.47 $113,683 - $131,112	2,762 Added 75.22%	6,434 $271,000
Q3 2020 Oct 20, 2020	BUY	$43.36 - $53.53 $131,467 - $162,302	3,032 Added 473.75%	3,672 $168,000
Q2 2020 Jul 27, 2020	BUY	$46.37 - $57.58 $23,185 - $28,790	500 Added 357.14%	640 $32,000
Q1 2020 Apr 17, 2020	BUY	$40.22 - $62.0 $2,011 - $3,100	50 Added 55.56%	140 $7,000
Q3 2018 Oct 16, 2018	BUY	$85.46 - $126.37 $7,691 - $11,373	90 New	90 $8,000

Others Institutions Holding ENTA

# of Institutions

109

Shares Held

21.2M

Call Options Held

4.8K

Put Options Held

4.6K

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $106M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Enanta Pharmaceuticals Inc Transaction History